Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Q-Cells SE To File For Insolvency - Quick Facts

Q-Cells SE (QCLSF.PK) would file for insolvency proceedings on Tuesday, 3 April 2012, at the competent Insolvency Court in Dessau. Against the backdrop of the final ruling of the Frankfurt Higher Regional Court in the Pfleiderer case on March 27, 2012, the company had come to the conclusion that no going concern prognosis is given anymore.

After an intensive review of alternative concepts for the implementation of the financial restructuring, the Executive Board has concluded that a going concern of the company cannot be restored on a sufficiently secure legal basis. Hence, the filing for insolvency proceedings is legally necessary. The Executive Board and the preliminary insolvency administrator would work together to secure the continuity of the company within the insolvency proceedings.

Click here to receive FREE breaking news email alerts for Q-Cells SE and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After trending higher over the past several sessions, stocks showed a lack of direction throughout the trading day on Friday before closing roughly flat. A muted reaction to a highly anticipated speech by Federal Reserve Chair Janet Yellen contributed to the lackluster performance. Republican Scott Brown has significantly narrowed the gap in the race against incumbent New Hampshire Sen. Jeanne Shaheen, D-N.H., according to the results of a new WMUR Granite State Poll. On the heels of the violent clashes between local police and protestors in Ferguson, Missouri, Sen. Claire McCaskill, D-Mo., announced that she will hold a Senate hearing in September to examine the militarization of local police departments.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.